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Ten cases of Kaposi's sarcoma {KS) including five AIDS-KS, 
one classical KS, and four pseudo-KS (acroangiodermatitis) 
were investigated for their expression of basic fibroblast 
growth factor. Antigen expression was demonstrated by im-
munoperoxidase staining of cryostat sections with affinity-
purified anti-bFGF antibodies. 
It was found that bFGF was strongly expressed in basal and 
suprabasal keratinocytes, which were also intensively stained 
in normal skin biopsies. The growth factor was generally 
K aposi's sarcoma (KS) was first described more than 100 years ago as a rare disease affecting redomi-nandy elderly men of Caucasian ancestry [1 f. During the last years, a dramatic change has occurred in the epidemiology due to the association of Kaposi's sar-
coma with acquired immuno-deficiency syndrome. 
The neoplasm is a multifocal lesion of unclear histogenesis and 
unknown pathogenesis. It reveals a complex histologic pattern 
characterized by the presence of irregular vascular elements and 
proliferative spindle-shaped structures. The former have been iden-
tified as endothelial cells based on the presence of W eibel-Palade 
bodies· and von-Willebrand factor. There is no general agreement 
about the origin of the spindle cell component (reviewed in [2,3}). 
Most recent evidence in which lesions were analyzed by immune-
and enzyme-histochemical comparison favors a histogenesis of Ka-
posi's sarcoma cells from vascular endothelium [4,5). 
Besides the unclear cellular origin, the pathogenic mechanisms 
leading to Kaposi's sarcoma are totally unknown. The incidence of 
Kaposi's sarcoma in patients under immunosuppressive therapy [6) 
and the absence of retroviral DNA sequences in AIDS-lesions [7) 
argues against a direct viral etiology of Kaposi's sarcoma. The unre-
stricted growth of Kaposi's sarcoma cells was explained hypotheti-
cally either by viral-dependent protoon.cogene activ~tion or by 
mechanisms in which abnormal production of autocnne ·or para-
crine growth factors lead to cell proliferation. Delli Bovi et al [8] 
isolated a KS-derived oncogene called hst/k-fgf whose product has 
homology to the fibroblast growth factors. Amplifications or rear-
rangements of certain oncogenes, however, which are generally 
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absent from the endothelial cells and spindle cells of th~ 
neoplasms. These cell types exhibited a very faint staining ~ 
a small number of lesions. 
The studies provide strong evidence that proliferation ot 
KS tumor cells may not be explained by autocrine secretiolj, 
mechanism of the growth factor, which has been suggeste~ 
in previous reports with in vitro cultured KS cell lines.] Inves~ 
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believed to be involved in tumorigenesis cannot be observed ~ 
Kaposi's sarcoma [9). 
Recent investigations of Ensoli et al (10] suggest that prolifera, 
tion of KS cells may be caused by the autocrine production an4 
high-level expression of basic fibroblast growth factor (bFGF) an~ 
interleukin 1. As these data were elaborated from in vitro culture<t: 
cells that may not necessarily correlate to in vivo situations, it w~ 
the aim of our study to examine the in situ expression ofbFG Pus in~ 
the indirect immunoperoxidase technique. 
MATERIALS AND METHODS 
Antibodies Polyclonal antibodies against bFGF were kindly pro\ 
vided by Dr. W. Risau (Max-Planck-Institute of Psychiatry, Mar\ 
tinsried, FRG). The antibodies were raised in rabbits using recombi\ 
nant human bFGF for immunization [11]. They specifically detec\ 
bFGF but not acidic FGF in Western blots at a 1000-times-highe~ 
dilution of the antisera (Risau et al, manuscript in preparation). Fo~ 
immunohistology, the antibodies were purified by affinity chroma\ 
tography over bFGF-coupled sepharose. 
Polyclonal antibodies against factor VIII- related antigen w~ 
purchased from Dakopatts (Denmark). 
Im~unohistology Immunostaining on cryostat sections was es, 
senttally performed as described [ 12]. Briefly, cryostat sections we~ 
air dried, fixed in acetone, and preincubated with 50% normal goa~ 
serum (NGS) in PBS. After 30 min, anti-bFGF antibodies (l.S 
{lg/ml, diluted in 10% NGS) were incubated for 90 min. Bounq 
antibodies were detect.ed with goat-anti-rabbit IgG-peroxidas~ 
conjugate (Dianova, Hamburg, FRG) followed by developmen~ 
with 3-amino-4-ethylcarbazole: Sections were counterstained with 
Mayer's hemalaun and embedded in Aquamount. 
Controls were performed either by a) replacing the anti-bFGR 
IgG with corresponding amounts of normal rabbit IgG orb) adsorp, 
tion of anti-bFGF IgG with a tenfold excess of recombinant humatj 
bFGF prior to the incubation. 
RESULTS 
Cryostat sections of 10 cases of Kaposi's sarcoma including five 
AIDS-KS, one classical KS, and four pseudo-KS (acroangioderma, 
titis) were examined. All lesions were restricted to the skin excep\ 
one of classical KS, which was taken from the oral mucosa. Tb~ 
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Figure 1. Light micrograph offactor VIII expression in AIDS-KS. Staining 
was performed wtth a polyclonal antiserum against factor VIII - related anti-
gen. Sections were counterstained with ·Mayer's hemalaun. Factor VIII is 
expressed in nearly all blood vessels (arrows, magnification XlSO). 
sections all revealed a typical histologic pattern of irregular vascular 
elements lined with pleiomorphic endothelial cells and spindle-
shaped cell structures. In most cases, extravasation of erythrocytes 
and hemosiderin deposition was observed. In three biopsies of 
pseudo-KS and one of AIDS-KS no spindle cells were found. 
Factor VIII staining was strongest in non-neoplastic cells of small 
capillaries, arterioles, and veins, whereas poorly differentiated en-
dothelial cells were less intensely stained (Fig 1). Spindle cells were 
always negatively stained, consistent with the observations of other 
investigators (4,5] . 
Staining with anti-bFGF antibodies revealed that expression of 
the growth factor was mainly restricted to the basal and suprabasal 
layer of the epidermis, where keratinocytes showed a large accumu-
lation of bFGF (Fig 2). Staining was clearly specific, because con-
trols using non-immune lgG or adsorption of the antiserum against 
recombinant bFGF abolished the staining. Besides strongly stained 
keratinocytes, other cell types such as vascular or spindle-shaped 
cells were largely devoid of bFGF. These cell types also remained 
unlabeled with higher concentrations (up to 10 J.Lg/ml) of the anti-
bodies. Some biopsies (two of pseudo-KS and one of AIDS-KS) 
additionally exhibited a faint staining of endothelial and spindle 
cells, whereby mainly more differentiated endothelial cells weakly 
expressed bFGF. Staining, however, was only found in single scat-
tered cells. There were no differences in the staining reactiviry 
between the various forms of Kaposi's sarcoma and normal skin 
biopsies (Fig 3). 
Figure 2. Detection of bFGF in AIDS-KS. Conspicuous expression is 
found in keratinocytes (arrows). Endothelial and spindle cells do not reveal 
any detectable amounts ofbFGF (magnification X95). 
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Figure 3. Staining of bFGF in normal skin. Expression of bFGF is also 
exclusively found in keratinocytes (arrow, magnification X180). 
Due to the negative staining of the hyper- and neoplastic cells 
observed in Kaposi's sarcoma we further analyzed bFGF expression 
in other kinds of vascular proliferations such as granuloma pyogeni-
cum (four), hemangiosarcoma (two), and capillary hemangioma 
(five). Although also in the first two lesions keratinocytes were the 
exclusively stained cell type, hemangioma exhibited an additional 
staining of neoplastic vascular cells with a more pronounced reac-
tion in differentiated tumor cells (Fig 4 ). 
DISCUSSION 
The recent findings of Ensoli et al (10] that Kaposi's sarcoma-
derived cell lines are characterized by a pronounced expression of 
basic fibroblast growth factor and interleukin 1 prompted us to 
investigate the presence ofbFGF in situ using the indirect immune-
peroxidase technique. In contrast to these authors, we do not find a 
pronounced expression of the growth factor in neoplastic KS cells. 
Staining ofKS lesions was not alter.::d in comparison to normal skin. 
In both tissues, bFGF seemed to be confined to the epidermal cells 
where large amounts were accumulated, especially in the basal and 
suprabasal keratinocytes. Other cell rypes generally did not exhibit 
any detectable expression of the growth factor. Faint staining was 
only observed in individual endothelial cells or single scattered 
tumor cells of some lesions . This is particularly striking because we 
have previously shown [13] that bFGF is largely enhanced in other 
skin tumors such as melanoma and basal cell carcinoma and other 
neoplasms as, e.g., osteosarcoma or gastric and mamma carcinoma. 
Figure 4. Positive staining ofbFGF expression in endothel ial cells (arro 1vs) 
of capillary hemangioma (magnification X240). 
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Therefore, pronounced expression of bFGF in cultured KS cells 
may not necessarily be correlated to in vivo situations. 
Recently published studies in which skin-derived KS cell lines 
were analyzed by Northern blotting with various FGF- and FGF-
related gene probes also failed to demonstrate elevated bFGF-ex-
pression [14]. These data are in line with our in vivo findings. 
Differences from results obtained by Ensoli et al [10] may be due to a 
generally observed discrepancy between cellular phenotypes under 
in vivo and in vitro conditions. Additionally, also the differences in 
the origin of the analyzed cell types may contribute to the different 
results, as Ensoli et al [10] used cell lines derived from lung biopsies 
and pleural effusions (15]. 
There are, however, several reasons making it unlikely that 
bFGF-expression is the cause of the abnormal proliferation of Ka-
posi's sarcoma cells. Basic FGF is lacking a classical hydrophobic 
signal sequence responsible for external secretion of the growth 
factor (16]. So the mechanism by which bFGF might be released is 
totally unknown yet. Rogelj eta! [17] observed that transformation 
of transfected cells only occurred with a bFGF-construct that con-
tained the IgG signal sequence fused 5' to the bFGF coding se-
quence. Transfections with constructs coding only for bFGF 
yielded no trans formants . Other investigators found transformation 
of cell lines with extremely high concentrations of the growth 
factor that would, however, hardly be expressed by tumor cells [18]. 
The transforming potential of another recently described member 
of the FGF fam ily exhibiting a typical signal sequence like hst/k-fgf 
[8] was shown to be 10 to 100 times higher in comparison to bFGF. 
It will be interesting to investigate whether members of the FGF 
family such as hst/k-fgf or FGF-5 [19] or still uncharacterized FGF 
[1 4] might be involved inKS lesions.. . 
It is notable that other authors d1d not observe an autocnne 
growth effect ofbFGF on KS cells but a strong dependence of th~se 
cells on platelet-derived growth factor (20] . Externally s~pphed 
platelet-derived growth factor may be secreted by endothehal cells 
or extravasated platelets of the highly vacularized tumor. Therefore 
it can be suggested that paracrine rather than autocrine mechanisms 
may be the cause for proliferation of KS cells .. This is in accordance 
with the relatively low mahgnancy and mab1hty ofKS cells to grow 
in nude mice [5] . · 
Taken together, our data and other data make it unlikely that 
bFGF is the primary agent participating in the etiology of Kaposi's 
sarcoma. The fact that the growth factor is stored in large amounts 
in keratinocyes and extracellular matrix [21] suggests a repair-me-
diated role whereby bFGF is only released upon tissue injury and 
cell lysis. 
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